GO
Loading...

Pfizer Inc

More

  • FDA panel votes to keep boxed warning on Chantix Thursday, 16 Oct 2014 | 4:10 PM ET

    WASHINGTON— Federal health advisers say a bold-letter warning about suicide risks with Pfizer's Chantix should remain on the anti-smoking drug until it can reevaluated based on new, rigorous study information. Eleven advisers to the Food and Drug Administration voted to retain the so-called black box warning about reports of suicide, hostility and...

  • Can health-care stock funds stay on top? Thursday, 16 Oct 2014 | 2:53 PM ET

    NEW YORK— When swings in the stock market cause anxiety to spike, like it is now, many investors aim to get healthy. Stocks don't come with guarantees, but health care stocks have held up better than others during past downturns. People get sick regardless of the economy's strength, after all, and an aging population around the world means more demand for...

  • Most active New York Stock Exchange-traded stocks Thursday, 16 Oct 2014 | 1:21 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AbbVie fell 3.2 percent to $52.90 with 57,113,900 shares traded. Advanced Micro Devices Inc. rose 1.1 percent to $2.64 with 36,641,000 shares traded.

  • Midday Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 1:21 PM ET

    Baxter International Inc. rose$. 65 or 1.0 percent, to $68.99. Bristol-Myers Squibb Co. rose$. 30 or. 6 percent, to $49.26. Hospira rose$. 61 or 1.3 percent, to $48.73.

  • Early Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 11:35 AM ET

    Baxter International Inc. fell $1.01 or 1.5 percent, to $67.33. Bristol-Myers Squibb Co. rose$. 25 or. 5 percent, to $49.21. Hospira rose$. 32 or. 7 percent, to $48.44.

  • Oct 16- Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow. The company, whose profit topped expectations for the fourth straight quarter, cut its 2014 earnings forecast to $4.86- $4.89 per share to exclude gains from its vaccine business that it...

  • *AbbVie board recommends shareholders vote against deal. *AbbVie to pay Shire $1.64 bln break fee if deal collapses. LONDON, Oct 16- U.S. drugmaker AbbVie has pulled the plug on its plan to buy Dublin- based Shire, recommending shareholders vote against the planned $55 billion takeover following new U.S. tax rules.

  • *AbbVie board recommends shareholders vote against deal. *AbbVie to pay Shire $1.64 bln break fee if deal collapses. LONDON, Oct 16- U.S. pharmaceutical company AbbVie has pulled the plug on its plan to buy Dublin- based drugmaker Shire, recommending shareholders vote against the planned $55 billion takeover following new U.S. tax rules.

  • Final Glance: Pharmaceuticals companies Wednesday, 15 Oct 2014 | 6:07 PM ET

    Baxter International Inc. fell$. 52 or. 8 percent, to $68.34. Bristol-Myers Squibb Co. rose$. 04 or. 1 percent, to $48.96. Eli Lilly& Co. fell$. 27 or. 4 percent, to $62.87.

  • NEW YORK, Oct 15- A federal judge in Manhattan will soon have to weigh in on how the family of a convicted insider trader should live while the man spends nearly a decade in federal prison. The wife of Mathew Martoma, who was caught using secret tips to trade two stocks while working for SAC Capital Advisors, asked a court on Wednesday to let her keep the couple's $2.2...

  • NEW YORK, Oct 15- For the first nine months of this year, U.S. fund managers could be counted on to tout the same line: the stock market was getting so expensive they could do nothing but sit on their hands. "We're finally getting busy again," said Scott Moore, the lead portfolio manager of the Buffalo Dividend Focused fund, the top-performing large-cap fund for the year to...

  • Midday Glance: Pharmaceuticals companies Wednesday, 15 Oct 2014 | 1:17 PM ET

    Baxter International Inc. fell $1.69 or 2.5 percent, to $67.17. Bristol-Myers Squibb Co. fell$. 57 or 1.2 percent, to $48.35. Hospira fell $1.32 or 2.7 percent, to $47.00.

  • Most active New York Stock Exchange-traded stocks Wednesday, 15 Oct 2014 | 1:17 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. rose. 1 percent to $33.87 with 47,606,700 shares traded. AbbVie rose. 9 percent to $54.63 with 68,089,600 shares traded.

  • Early Glance: Pharmaceuticals companies Wednesday, 15 Oct 2014 | 10:46 AM ET

    Baxter International Inc. fell $1.10 or 1.6 percent, to $67.76. Bristol-Myers Squibb Co. fell$. 64 or 1.3 percent, to $48.28. Hospira fell$. 37 or. 8 percent, to $47.94.

  • *AbbVie says reconsidering backing for deal. *AbbVie board to meet on Oct. 20. LONDON, Oct 15- Chicago- based AbbVie said it was reconsidering its $55 billion takeover of Shire weeks after the U.S. government moved to curb deals designed to reduce tax, wiping $13 billion off the London- listed firm's stock price.

  • LONDON, Oct 15- European shares fell on Wednesday, weighed down by UK healthcare stocks after U.S. suitor AbbVie Inc said it would reconsider its bid for UK pharmaceutical firm Shire. Shares in Shire fell nearly 30 percent in early deals after AbbVie said it intended to reconsider its recommendation to shareholders to vote in favor of the 32 billion pound merger...

  • Oct 14- AbbVie Inc said it intends to reconsider its recommendation to its shareholders to vote in favor of the 32 billion pound merger with Shire Plc due to the changing U.S. tax regulations. Chicago- based AbbVie, which makes top-selling arthritis drug Humira, is eager to buy Shire to reduce its U.S. tax bill by moving its tax base to Britain and to diversifying its...

  • Final Glance: Pharmaceuticals companies Tuesday, 14 Oct 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 80 or 1.1 percent, to $68.86. Bristol-Myers Squibb Co. fell$. 17 or. 3 percent, to $48.92. Hospira fell$. 04 or. 1 percent, to $48.31.

  • Midday Glance: Pharmaceuticals companies Tuesday, 14 Oct 2014 | 1:42 PM ET

    Baxter International Inc. rose$. 01 or percent, to $69.67. Bristol-Myers Squibb Co. rose$. 03 or. 1 percent, to $49.12. Hospira rose$. 43 or. 9 percent, to $48.78.

  • Oct 14- Pfizer Inc's quit-smoking drug Chantix received its latest setback on Tuesday after U.S. Food and Drug Administration staff recommended that the drugmaker keep a severe warning on the treatment's label. Chantix is one of Pfizer's most controversial drugs and has a number of severe side effects, including suicidal thoughts, erratic behavior and...